EODData

MEMBERSHIP REGISTER LOG IN

FRA, 0VY: I-MAB SPONS.ADS/1 -0001

15 May 2026
LAST:

1.620

CHANGE:
 0.11		OPEN:
1.620		HIGH:
1.620		ASK:
0.000		VOLUME:
0
CHG(%):
6.36		PREV:
1.730		LOW:
1.620		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 May 261.6201.6201.6201.6200
14 May 261.7301.7301.7301.7300
13 May 261.7401.7401.7401.7400
12 May 261.7501.7501.7501.7500
11 May 261.8401.8401.8401.8400
08 May 261.8501.8501.8501.8500
06 May 262.0202.0202.0202.0200
05 May 262.0402.0402.0402.0400
04 May 262.0002.0002.0002.000106
30 Apr 261.9901.9901.9901.9900

PROFILE

Name:I-MAB SPONS.ADS/1 -0001
About:I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:2440 Research Boulevard, Rockville, MD, United States, 20850
Website:https://www.i-mabbiopharma.com
ISIN:US44975P1030
LEI:549300L1A5T19703RR64

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-14.78 
Forward P/E:-2.86 
PEG Ratio:0.12 
Price to Sales:24.78 
Price to Book:1.75 
Return on Assets:-0.10 
Return on Equity:-0.18 
Revenue:569.5K 
Shares:81.66M 
Market Cap:132.29M 

TECHNICAL INDICATORS

MA5:1.747.2%
MA10:1.8614.7%
MA20:2.0124.1%
MA50:2.2237.0%
MA100:2.6664.2%
MA200:3.1091.2%
RSI14:17.86 
WPR14:-100.00 
MTM14:-0.46
ROC14:-0.22 
ATR:0.06 
Week High:1.8514.2%
Week Low:1.620.0%
Month High:2.2840.7%
Month Low:1.6291.2%
Year High:5.60245.7%
Year Low:0.77110.4%
Volatility:28.21